Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression profile of PBMCs following decitabine treatment


ABSTRACT: The epigenetic regulation, for example, DNA methylation, controls the development and differentiation of both tumor cells and immunocytes. Treatment with DNA demethylating agent (such as decitabine) has shown a dramatic clinical benefit in hematological malignancies and solid tumors. However, the influence of epigenetic therapy on host immune system remains unclear. To investigate the effects of low-dose decitabine therapy on T cells, We collected whole blood samples from two solid tumor patients pre and post low-dose decitabine therapy, and detected the expression profiles of PBMCs.

ORGANISM(S): Homo sapiens

SUBMITTER: Jing Nie 

PROVIDER: E-GEOD-72686 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2012-12-18 | E-GEOD-40442 | biostudies-arrayexpress
2016-01-20 | E-GEOD-76948 | biostudies-arrayexpress
2016-08-23 | E-GEOD-85885 | biostudies-arrayexpress
2016-02-06 | E-GEOD-77517 | biostudies-arrayexpress
2016-03-30 | E-GEOD-79693 | biostudies-arrayexpress
2016-08-13 | E-GEOD-85537 | biostudies-arrayexpress
2015-11-10 | E-GEOD-74707 | biostudies-arrayexpress
2015-11-10 | E-GEOD-74742 | biostudies-arrayexpress
2016-02-26 | E-GEOD-71478 | biostudies-arrayexpress
2013-06-26 | E-GEOD-43978 | biostudies-arrayexpress